Page last updated: 2024-08-24

irinotecan and leukotriene c4

irinotecan has been researched along with leukotriene c4 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, XY; Dabbs, JE; Froehlich, R; Green, CE; Kato, Y; Niinuma, K; Sugiyama, Y; Suzuki, H; Tyson, CA; Ueda, K; Weizer, V1
Akiyama, S; Chen, ZS; Furukawa, T; Komatsu, M; Ono, K; Sumizawa, T; Tani, A1
Aikou, T; Akiyama, S; Aoki, S; Che, XF; Furukawa, T; Goto, S; Haraguchi, M; Igarashi, Y; Kanehisa, M; Kobayashi, M; Mitsuo, R; Nakajima, Y; Noguchi, T; Ren, XQ; Sumizawa, T; Takahashi, H; Tsujikawa, K1

Other Studies

3 other study(ies) available for irinotecan and leukotriene c4

ArticleYear
Biliary excretion mechanism of CPT-11 and its metabolites in humans: involvement of primary active transporters.
    Cancer research, 1998, Nov-15, Volume: 58, Issue:22

    Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Bile; Bile Canaliculi; Camptothecin; Humans; Irinotecan; Leukotriene C4; Rats; Rats, Sprague-Dawley

1998
An enhanced active efflux of CPT-11 and SN-38 in cisplatin-resistant human KB carcinoma cells.
    Cancer letters, 1999, Apr-26, Volume: 138, Issue:1-2

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP-Binding Cassette Transporters; Camptothecin; Cisplatin; DNA; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Humans; Irinotecan; KB Cells; Leukotriene C4; Multidrug Resistance-Associated Proteins

1999
MRP1 mutated in the L0 region transports SN-38 but not leukotriene C4 or estradiol-17 (beta-D-glucuronate).
    Biochemical pharmacology, 2005, Oct-01, Volume: 70, Issue:7

    Topics: Base Sequence; Camptothecin; Cell Line; Chromatography, High Pressure Liquid; DNA Primers; Estradiol; Humans; Irinotecan; Leukotriene C4; Multidrug Resistance-Associated Proteins; Photoaffinity Labels

2005